Claritev ROA 2019-2025 | CTEV

Current and historical return on assets (ROA) values for Claritev (CTEV) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Claritev ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-03-31 $-1.18B $5.09B -22.11%
2024-12-31 $-1.65B $5.15B -29.16%
2024-09-30 $-1.54B $5.32B -25.24%
2024-06-30 $-1.17B $5.74B -17.94%
2024-03-31 $-0.63B $6.37B -9.17%
2023-12-31 $-0.09B $6.97B -1.28%
2023-09-30 $-0.71B $7.06B -9.87%
2023-06-30 $-0.67B $7.14B -8.91%
2023-03-31 $-0.62B $7.22B -7.95%
2022-12-31 $-0.57B $7.37B -7.14%
2022-09-30 $0.10B $8.19B 1.25%
2022-06-30 $0.16B $8.22B 1.95%
2022-03-31 $0.10B $8.28B 1.21%
2021-12-31 $0.10B $8.22B 1.23%
2021-09-30 $-0.10B $8.28B -1.15%
2021-06-30 $-0.46B $8.34B -7.08%
2021-03-31 $-0.47B $8.36B -9.99%
2020-12-31 $-0.52B $8.28B -17.92%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.663B $0.931B
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.989B 58.51
Hims & Hers Health (HIMS) United States $13.669B 142.02
Tempus AI (TEM) United States $11.962B 0.00
IRhythm Technologies (IRTC) United States $4.646B 0.00
Inspire Medical Systems (INSP) United States $3.825B 59.77
Hinge Health (HNGE) United States $3.100B 0.00
Privia Health (PRVA) United States $2.659B 181.75
Enovis (ENOV) United States $1.751B 9.76
Schrodinger (SDGR) United States $1.545B 0.00
Phreesia (PHR) United States $1.527B 0.00
Clover Health Investments (CLOV) United States $1.511B 0.00
Azenta (AZTA) United States $1.371B 63.70
10x Genomics (TXG) United States $1.338B 0.00
Omnicell (OMCL) United States $1.324B 23.36
Fulgent Genetics (FLGT) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.534B 0.00
Veradigm (MDRX) United States $0.482B 0.00
Talkspace (TALK) United States $0.463B 138.50
Standard BioTools (LAB) United States $0.414B 0.00
Outset Medical (OM) United States $0.347B 0.00
TruBridge (TBRG) United States $0.346B 766.67
Nyxoah SA (NYXH) Belgium $0.263B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.150B 0.00
EUDA Health Holdings (EUDA) Singapore $0.139B 0.00
Pulmonx (LUNG) United States $0.111B 0.00
CareCloud (CCLD) United States $0.107B 4.06
American Well (AMWL) United States $0.106B 0.00
MDxHealth SA (MDXH) Belgium $0.096B 0.00
111 (YI) China $0.068B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.046B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.031B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00